ReviewBMJ (Clinical research ed.)2002
Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign.
Review in BMJ (Clinical research ed.), 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Thrombolysis for acute ischaemic stroke.The Cochrane database of systematic reviews · 2014Pooled it
- Thrombolytic therapy for acute ischemic stroke beyond three hours.The Journal of emergency medicine · 2011Pooled it
- Does declaration of competing interests affect readers' perceptions? A randomised trial.BMJ (Clinical research ed.) · 2002Trial
- Fifty Years of Acute Ischemic Stroke Treatment: A Personal History.Cerebrovascular diseases (Basel, Switzerland) · 2021Review
- Thrombolysis with alteplase 3-4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances.BMJ evidence-based medicine · 2020Article
- tPA for Acute Ischemic Stroke and Its Controversies: A Review.The Neurohospitalist · 2020Article
- Conflicts of interest disclosure forms and management in critical care clinical practice guidelines.Intensive care medicine · 2018Review
- Thrombolytic Treatment for Ischaemic Stroke: Could the Crisis of Confidence Have Been Avoided by Better Analysis of Trial Data?Drugs & aging · 2017Review
- Why don't more patients receive intravenous rt-PA for acute stroke?Expert review of neurotherapeutics · 2015Article
- Pharmaceutical sponsorship bias influences thrombolytic literature in acute ischemic stroke.The western journal of emergency medicine · 2011Article
- A user's guide to the NINDS rt-PA stroke trial database.PLoS medicine · 2008Article
- [Therapeutic hypothermia after cardiopulmonary resuscitation - pro and con].Wiener medizinische Wochenschrift (1946) · 2008Article
- Foundations and task forces.Mens sana monographs · 2007Article
- Concerned Journals, Editors And ICMJE.Mens sana monographs · 2007Article
- New treatments in acute ischemic stroke.Current treatment options in neurology · 2005Article
- Review
- What do we really know about conflicts of interest in biomedical research?Psychopharmacology · 2003Review
- Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.BMJ (Clinical research ed.) · 2003Article
- Getting it right: industry sponsorship and medical research.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2003Article
- Management of stroke.Postgraduate medical journal · 2003Review
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.